The popularity of Viagra initially drove a surge for major pharmaceutical companies, however recent changes present a complicated scenario for shareholders. Generic alternatives are eating into revenue, and ongoing https://zakariawgnl338010.ourcodeblog.com/41575959/the-blue-pill-and-big-pharma-a-precarious-investment